MoneyWorks4Me

Supriya Lifescience - Quaterly Results

28 May 2024 Evaluate
The Revenue for the quarter ended  March 2024 of Rs. 1581.80 millions grew by 11.18 % from Rs. 1422.70 millions.A slender decline of -3.40% was recorded to Rs. 369.31  millions from Rs. 382.29 millions in the corresponding previous quarter.Operating profit surged to 576.89 millions from the corresponding previous quarter of 570.10 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 1581.80 1422.70 11.18 5703.70 4609.38 23.74 5703.70 4609.38 23.74
Other Income 21.85 19.64 11.25 106.35 94.89 12.08 106.35 94.89 12.08
PBIDT 576.89 570.10 1.19 1836.11 1383.87 32.68 1836.11 1383.87 32.68
Interest 6.01 7.14 -15.83 21.10 30.84 -31.58 21.10 30.84 -31.58
PBDT 570.88 562.96 1.41 1815.01 1353.03 34.14 1815.01 1353.03 34.14
Depreciation 39.14 30.07 30.16 158.11 118.15 33.82 158.11 118.15 33.82
PBT 531.74 532.89 -0.22 1656.90 1234.88 34.17 1656.90 1234.88 34.17
TAX 162.43 150.60 7.86 465.76 336.30 38.50 465.76 336.30 38.50
Deferred Tax 72.99 18.53 293.90 94.76 29.49 221.33 94.76 29.49 221.33
PAT 369.31 382.29 -3.40 1191.14 898.58 32.56 1191.14 898.58 32.56
Equity 160.97 160.97 0.00 160.97 160.97 0.00 160.97 160.97 0.00
PBIDTM(%) 36.47 40.07 -8.99 32.19 30.02 7.22 32.19 30.02 7.22
Peers
Company Name CMP
Sun Pharma. Inds. 1760.60
Dr. Reddys Labs. 1220.75
Cipla 1333.70
Lupin 1959.20
Zydus Lifesciences 1140.75
View more..